# A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

> **NCT02003547** · PHASE1 · COMPLETED · sponsor: **Amakem, NV** · enrollment: 21 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension
- Eye Disease

## Interventions

- **DRUG:** AMA0076
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02003547
- **Lead sponsor:** Amakem, NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02003547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02003547, "A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02003547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*